Procter & Gamble (NYSE:PG – Get Free Report) posted its quarterly earnings data on Wednesday. The company reported $1.88 EPS for the quarter, beating the consensus estimate of $1.86 by $0.02, Zacks reports. The business had revenue of $21.88 billion for the quarter, compared to the consensus estimate of $21,657,595.49 billion. Procter & Gamble had a return on equity of 32.88% and a net margin of 18.35%. Procter & Gamble’s revenue for the quarter was up 2.1% on a year-over-year basis. During the same quarter in the prior year, the business earned $1.84 earnings per share. Procter & Gamble updated its FY 2025 guidance to 6.910-7.050 EPS and its FY25 guidance to $6.91-$7.05 EPS.
Procter & Gamble Trading Up 0.9 %
NYSE PG opened at $166.20 on Friday. The company has a quick ratio of 0.55, a current ratio of 0.76 and a debt-to-equity ratio of 0.49. The stock’s 50-day simple moving average is $168.97 and its two-hundred day simple moving average is $169.38. Procter & Gamble has a twelve month low of $152.06 and a twelve month high of $180.43. The company has a market capitalization of $391.41 billion, a price-to-earnings ratio of 26.46, a PEG ratio of 3.69 and a beta of 0.45.
Procter & Gamble Dividend Announcement
The business also recently announced a quarterly dividend, which will be paid on Tuesday, February 18th. Investors of record on Friday, January 24th will be given a $1.0065 dividend. The ex-dividend date is Friday, January 24th. This represents a $4.03 annualized dividend and a yield of 2.42%. Procter & Gamble’s dividend payout ratio (DPR) is presently 64.17%.
Insider Transactions at Procter & Gamble
Wall Street Analysts Forecast Growth
Several brokerages recently weighed in on PG. Royal Bank of Canada reissued a “sector perform” rating and issued a $164.00 price objective on shares of Procter & Gamble in a report on Thursday. UBS Group lowered their price target on shares of Procter & Gamble from $196.00 to $189.00 and set a “buy” rating on the stock in a research report on Thursday, January 16th. Evercore ISI upped their price target on shares of Procter & Gamble from $180.00 to $183.00 and gave the company an “outperform” rating in a research note on Monday, October 21st. Wells Fargo & Company boosted their target price on shares of Procter & Gamble from $176.00 to $180.00 and gave the company an “overweight” rating in a report on Thursday. Finally, Morgan Stanley raised their price target on Procter & Gamble from $174.00 to $191.00 and gave the stock an “overweight” rating in a report on Monday, October 21st. Eight analysts have rated the stock with a hold rating, fourteen have issued a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $180.25.
About Procter & Gamble
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Featured Articles
- Five stocks we like better than Procter & Gamble
- How to buy stock: A step-by-step guide for beginners
- Why Energy Transfer Stock Could Soar to New Highs in 2025
- How to Use High Beta Stocks to Maximize Your Investing Profits
- 3 Buy-and-Hold Stocks for Long-Term Growth
- 3 REITs to Buy and Hold for the Long Term
- Despite Short-Term Risks Freeport McMoran Worth a Look
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.